Literature DB >> 23267449

The routine use of tranexamic acid in hip and knee replacements.

Jaykar R Panchmatia1, Soudeh Chegini, Charlotte Lobban, Guarangkumar Shah, Clare Stapleton, Jayne M B Smallman, Rakesh Kucheria.   

Abstract

PURPOSE: Our aim was to determine whether the administration of intravenous tranexamic acid is a safe and effective means of reducing blood loss associated with hip and knee replacement surgery.
METHOD: Sequential cohort study analysing hemoglobin titers, transfusion rates, and the occurrence of venous thromboembolism in patients undergoing hip and knee replacements with and without the administration of tranexamic acid at the time of induction. Finally, a cost benefit analysis was performed.
RESULTS: Two hundred and seventy-three patients were included in our study. We demonstrated that 1 gram of tranexamic acid administered intravenously at the time of induction significantly reduces operative blood loss and transfusion rates (p < 0.05). Moreover, the use of tranexamic acid reduces the costs associated with surgery.
CONCLUSIONS: The administration of 1 gram of intravenous tranexamic acid is a safe and effective means of reducing operative blood loss and blood transfusion rates in patients undergoing hip and knee replacements.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23267449

Source DB:  PubMed          Journal:  Bull NYU Hosp Jt Dis        ISSN: 1936-9719


  2 in total

1.  Blood transfusion in hip and knee arthroplasties: the end of the pre-operative group and save?

Authors:  B A Marson; J Shah; M Deglurkar
Journal:  Eur J Orthop Surg Traumatol       Date:  2015-01-30

Review 2.  Oral tranexamic acid reduces blood loss in total-knee arthroplasty: A meta-analysis.

Authors:  Hua Li; Liqun Bai; Yunhai Li; Zhiyuan Fang
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.